Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) and related Prospectus of Reata Pharmaceuticals, Inc. for the registration of Class A common stock, Class B common stock, preferred stock, warrants, depositary shares, stock purchase contracts, stock purchase units, and rights and to the incorporation by reference therein of our reports dated March 1, 2021, with respect to the consolidated financial statements of Reata Pharmaceuticals, Inc., and the effectiveness of internal control over financial reporting of Reata Pharmaceuticals, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2020, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Dallas, Texas
November 8, 2021